ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716270 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716270; 2) Community: the network communities that were significantly associated with the response to NSC 716270; 3) Molecule: the relationships between components within communities and NSC 716270; 4) MDR: the compounds that were significantly associated with the NSC 716270.

NSC Compound Enrichment Correlation
NSC 741291 6-(3-hydroxy-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one 0.0285477013888569 0.61326715
NSC 741940 Null 0.0285477013888569 0.4009173
NSC 747825 3-(4-fluorophenyl)-8,9-dimethyl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl acetate 0.0285477013888569 0.53358419
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0285477013888569 0.2138154
NSC 753188 4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0285477013888569 0.2611495
NSC 756188 GSK718429A 0.0285477013888569 0.42305516
NSC 756406 GW852849X 0.0285477013888569 0.42465088
NSC 756407 GW853606X 0.0285477013888569 0.46350931
NSC 758465 SALINOMYCIN, SODIUM 0.0285477013888569 0.23545783
NSC 760476 5,6,7,8-tetrafluoronaphtho[2,3-c][1,2,5]thiadiazole-4,9-dione 0.0285477013888569 0.37972101
Total:77  Current:54    [First] [Prev] [Next] [Last]